The Food and Drug Administration proposed Friday further rollback of restrictions on blood donation based on abstinence and sexual history-related criteria.
U.S. health regulator
The U.S. Food and Drug Administration said the rules aim to reduce the risk of transfusion-transmitted HIV and are similar to those inThe proposed rule comes several years after the FDA reversed a 1980s guideline, which banned men who have sex with men from donating blood, but said they had to abstain from sex for at least a year before donating.In 2020, the agency shortened the abstinence period to three months amid a pandemic-driven shortage of blood supply.
The removal of time-based deferrals also applies to women who have sex with the men who have sex with other men, the FDA said.Under the new proposal, any prospective donor — regardless of gender or sexual orientation — other than those who report having a new sexual partner or multiple partners and having anal sex in the past three months, will be eligible to donate blood, provided all other eligibility criteria are met.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA food safety official resigns, cites structural issuesThe Food and Drug Administration's top food safety official has resigned.
Consulte Mais informação »
Senior FDA official resigns in wake of 2022 infant formula shortage, acknowledges FDA communication breakdownsFDA's Deputy Commissioner for Food Policy and Response, Frank Yiannas, has announced he is resigning from his post. His departure comes in the wake of last year's infant formula shortage, throughout which Yiannas held a prominent leadership role.
Consulte Mais informação »
FDA revokes emergency use of monoclonal drug, says it won’t work against circulating strainsThe Food and Drug Administration is halting the emergency use of Evusheld -- a monoclonal antibody treatment for COVID-19 -- because regulators believe it's no longer effective against dominant variants.
Consulte Mais informação »
FDA pulls authorization for AstraZeneca’s Covid antibody drug EvusheldThe drug, meant to prevent Covid in people with weakened immune systems, does not work against the predominant omicron subvariant XBB.1.5.
Consulte Mais informação »
FDA approves Eli Lilly's drug for rare blood cancerEli Lilly and Co said on Friday the U.S. health regulator approved its drug for the treatment of a rare form of blood cancer.
Consulte Mais informação »
FDA revokes authorization for key anti-COVID drug, a blow for vulnerable AmericansEvusheld was designed to protect immunocompromised people from serious cases of COVID-19, but the latest Omicron variants have rendered the drug useless.
Consulte Mais informação »